The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Adicet Bio, Inc. | COM | 007002108 | 2,973 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| Compass Therapeutics, Inc. | COM | 20454B104 | 3,487 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| Cullinan Oncology, Inc. | COM | 230031106 | 5,879 | 381,002 | SH | SOLE | 381,002 | 0 | 0 | ||
| Cue Health Inc. | COM | 229790100 | 20,478 | 1,527,103 | SH | SOLE | 1,527,103 | 0 | 0 | ||
| Gemini Therapeutics, Inc. | COM | 36870G105 | 7,086 | 2,435,125 | SH | SOLE | 2,435,125 | 0 | 0 | ||
| Kinnate Biopharma Inc. | COM | 49705R105 | 5,168 | 291,667 | SH | SOLE | 291,667 | 0 | 0 | ||
| Pardes Biosciences Inc | COM | 69945Q105 | 85,571 | 5,227,307 | SH | SOLE | 5,227,307 | 0 | 0 | ||
| Quantum-Si Incorporated | COM CL A | 74765K105 | 12,577 | 1,598,125 | SH | SOLE | 1,598,125 | 0 | 0 | ||
| Theseus Pharmaceuticals, Inc. | COM | 88369M101 | 5,945 | 468,820 | SH | SOLE | 468,820 | 0 | 0 | ||